Becton, Dickinson and Company

Babson Diagnostics, Inc. is a healthcare technology company based in Austin, Texas, focused on revolutionizing diagnostic blood testing by providing lab-quality results in retail settings such as pharmacies and grocery stores. Established in 2017, the company has developed an innovative device that collects blood samples from finger capillaries, requiring only a small volume—just one-tenth of that needed for traditional venipuncture methods. This approach allows for accurate diagnostic results to be obtained quickly, enhancing accessibility to essential health information for consumers. The samples are analyzed at CLIA-certified clinical laboratories, ensuring the reliability and quality of the testing process.

Valley Health System is a regional healthcare system that serves residents in northern New Jersey and southern New York. It is comprised of The Valley Hospital, Valley Home Care, and Valley Medical Group. Its services include cardiology, oncology, women’s and children’s services, emergency care, orthopedics, and neurosciences. Through its comprehensive inpatient and outpatient programs, highly skilled home care services, community-based medical practices, and wellness programs, and collaborations with some of the world's leading healthcare organizations, it is dedicated to keeping communities healthy.

Northeast valley health corporation (NEVHC) is one of the nation's community health centers. They are a nonprofit organization, focused on preventing and alleviating health issues. While their patients are united by their experience of medical need, they come from every walk of life and background. The mission of northeast valley health corporation is to provide, safe and comprehensive healthcare to the medically underserved residents of los angeles county, particularly in the san fernando and santa clarita valleys, in a manner that is sensitive to the economic, social, cultural, and linguistic needs of the community.

HealthNet provides high-quality medical, dental, behavioral health care and support services to people of all age, regardless of insurance.

Share Ourselves offers personalized care as a means to deliver quality services, improve population health and stability, and reduce costs. They also provides pediatric care, women's health, behavioral health, clinical pharmaceutical services, food pantry, financial assistance, homeless services, health education, case management, and an OB program.

Wahiawā Health provides access to affordable, quality health care and wellness services to promote a healthy community.

Day Zero Diagnostics Inc. is an innovative company focused on transforming infectious disease diagnostics through advanced sequencing technologies. Based in Boston, Massachusetts, the company has developed a rapid diagnostic system that identifies bacterial species and their antibiotic resistance profiles directly from clinical samples. Key technologies include Blood2Bac, which enriches bacterial DNA, and BacDetect, allowing for swift detection of bacterial DNA. Additionally, the company employs machine learning algorithms for genomic antibiotic susceptibility testing and maintains a comprehensive microbial database that integrates genomic sequencing data with resistance profiles. By enabling rapid and accurate diagnoses, Day Zero Diagnostics aims to address critical needs in managing bloodstream infections and sepsis, reducing the time for diagnosis from days to hours and improving patient outcomes through targeted treatments.

Cytognos is a privately held company that specializes in flow cytometry solutions, focusing on applications in blood cancer diagnosis, minimal residual disease detection, and immune monitoring for blood diseases. The company develops and provides a range of products, including reagents, devices, and software, aimed at enhancing the capabilities of flow cytometer laboratories. By offering intuitive and powerful tools, Cytognos seeks to improve the understanding of patient data, thereby facilitating advanced diagnostics and research in the field of hematology.

Scanwell Health, Inc. is a healthcare company that specializes in at-home diagnostic solutions, focusing on urine testing kits. Founded in 2018 and headquartered in Los Angeles, California, Scanwell Health has developed an FDA-cleared urine testing application that allows users to obtain clinical-grade results via their smartphones. The company's flagship product is a urinary tract infection test kit that not only provides accurate testing results but also connects users with online medical professionals for same-day treatment and prescriptions. By combining innovative technology with accessible healthcare services, Scanwell Health aims to enhance proactive health management for individuals seeking convenient and affordable medical care.

Tissuemed Ltd. is a medical technology company based in Leeds, United Kingdom, specializing in the development of tissue-based therapeutic devices, particularly surgical sealants. The company offers innovative products designed to prevent air, blood, and fluid leaks during surgical procedures, including cerebrospinal fluid leakage. Tissuemed's flagship product line, TissuePatch™, consists of synthetic, self-adhesive films that feature a multi-layer structure, promoting effective sealing while minimizing foreign body reactions. Established in 1985, Tissuemed has shifted its focus over the years to concentrate on surgical sealants, building on its extensive scientific expertise. The company distributes its products through a network of distributors both in the UK and internationally, and it also provides services related to polymer synthesis, formulation of films, and testing, supporting pre-clinical and clinical trials.

Venclose, Inc. is a medical technology company based in San Jose, California, founded in 2014. The company specializes in developing endovenous radiofrequency ablation therapy systems aimed at treating chronic venous insufficiency. Venclose's technology focuses on improving both the physician and patient experience during the treatment of damaged veins. The company's solutions facilitate ease of navigation and positioning during procedures, minimize invasiveness, and provide real-time data to inform treatment decisions. By enabling a straightforward catheter plug-in, Venclose empowers medical professionals to effectively address venous reflux, ultimately restoring healthy blood flow in patients.

Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company specializes in developing advanced technologies for minimally invasive surgical procedures, focusing on enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Its flagship product, the Vicarious Surgical Robotic System, integrates virtual reality software with human-like robotic capabilities, enabling surgeons to perform complex surgeries with greater precision and control. Designed for abdominal access through a single port, the system is compact and portable, facilitating easy integration into existing operating rooms. By minimizing invasiveness, Vicarious Surgical aims to accelerate patient recovery times and decrease post-operative discomfort, thereby transforming the landscape of surgical care.

HealthNet provides high-quality medical, dental, behavioral health care and support services to people of all age, regardless of insurance.

Tepha, Inc. is a medical device company based in Lexington, Massachusetts, specializing in the development and manufacturing of components derived from proprietary biomaterial technology. Incorporated in 1998, Tepha focuses on creating innovative products based on polyhydroxyalkanoates, a new class of absorbable biomaterials engineered using recombinant DNA technology. The company's offerings include monofilament sutures for soft tissue approximation, monofilament meshes for various surgical applications such as hernia and pelvic floor repair, and a P4HB regenerative polymer scaffold for treating stress urinary incontinence. Additionally, Tepha produces surgical films for tissue support and composite meshes designed to minimize tissue attachment. The advanced properties of Tepha's biomaterials, including flexibility, elasticity, biocompatibility, and tensile strength, position the company to address unmet needs in the medical device industry across multiple fields.

Velano Vascular, Inc. is a medical device company based in San Francisco, California, focused on innovating blood collection practices to enhance patient care and reduce associated risks. Founded in 2011, the company has developed the PIVO device, a needle-free and single-use sterile tool designed to draw blood from indwelling peripheral IV lines. This device aims to minimize the number of needle sticks and central line access required for blood collection. By enabling frequent and high-quality blood draws, the PIVO device seeks to deliver a more compassionate and efficient healthcare experience for hospital inpatients while also providing a safer solution for healthcare providers. Velano Vascular is dedicated to addressing the challenges of vascular access and improving the overall efficiency of blood collection in clinical settings.

GSL Solutions is a medical technology company that specializes in the development of devices designed for the storage and tracking of controlled substances and patient-specific medications. The company offers innovative products, including IntelliCab, IntelliVault, IntelliVault MTB, and IntelliVault RD, which enhance the security, efficiency, and compliance of medication storage. Through these devices, GSL Solutions aims to improve inventory management, regulatory compliance, and patient safety, while also providing analytics capabilities to optimize the handling of medications.

Cubex Systems is a developer of cloud-based inventory management software specifically designed for the healthcare sector, including medical, dental, and veterinary markets. The software provides real-time reporting and intuitive analytics that focus on operational demands, spend management, and regulatory compliance. By utilizing this technology, clients can effectively lower medication costs and enhance their inventory supply management processes. This enables healthcare providers to optimize their operations while ensuring compliance with industry regulations.

TVA Medical, Inc. is a medical device company based in Austin, Texas, specializing in the development and manufacturing of catheter-based equipment for treating end-stage renal disease and peripheral vascular diseases. Founded in 2009, TVA Medical focuses on innovative, minimally invasive therapies, notably its everlinQ endoAVF system, which creates an arteriovenous fistula using an endovascular approach to facilitate hemodialysis for patients with kidney failure. This method is designed to be less invasive than traditional surgical techniques, resulting in reduced trauma to blood vessels. As of July 2018, TVA Medical operates as a subsidiary of Becton, Dickinson and Company.

MedAware Ltd is a company focused on enhancing patient safety and reducing healthcare costs through innovative solutions that detect and eliminate prescription errors. Established in 2012 and based in Raanana, Israel, MedAware employs advanced data analytics and machine learning algorithms to analyze extensive electronic medical records. Its key products include the MedAS alerting system, which provides real-time notifications to prevent prescription errors, as well as decision support tools such as MedRIM for risk management, MedQC for quality control, and MedRAF to reduce alert fatigue. By offering these solutions to healthcare providers, pharmacy benefit management companies, and pharmacy chains, MedAware aims to improve the accuracy of prescriptions and mitigate potential risks associated with drug interactions, dosages, and allergies.

Magentiq Eye Ltd. is a medical device company based in Haifa, Israel, established in 2014. The company specializes in enhancing endoscopic procedures through advanced technologies such as artificial intelligence, deep learning, and computer vision. Its flagship product is the Automatic Polyp Detection System (APDS), which aids physicians during colonoscopy by automatically identifying suspicious polyp locations in real-time or in offline mode on pre-recorded videos. This innovation is designed to improve the accuracy of polyp detection, thereby reducing the miss-rate associated with colonoscopies, which can lead to interval cancer. Given the high volume of colonoscopy procedures performed annually, Magentiq Eye's solutions aim to enhance diagnostic effectiveness, ultimately contributing to better patient outcomes and significant healthcare cost savings. The APDS can be integrated with existing colonoscopy systems or offered as a service to clinics and hospitals, positioning Magentiq Eye as a key player in the medical device industry focused on improving endoscopic practices.

C. R. Bard, based in Murray Hill, New Jersey, is a prominent multinational company focused on the development, manufacturing, and marketing of innovative medical technologies. The company provides a range of specialized medical devices aimed at addressing the challenges faced by healthcare professionals and patients in various aspects of healthcare, including wellness, prevention, early diagnosis, treatment, and post-care management. C. R. Bard's product portfolio encompasses solutions for conditions such as peripheral vascular disease, end-stage renal disease, heart arrhythmias, urology diseases, various cancers, and soft tissue repairs. By offering advanced vascular, urology, oncology, and surgical specialty products, C. R. Bard aims to enhance patient outcomes and improve the overall quality of care in the medical field.

Caesarea Medical Electronics Ltd. specializes in designing and manufacturing a variety of infusion and syringe pump systems. Based in Caesarea, Israel, the company offers products such as epidural infusion pumps, dual and four-channel infusion pumps, ambulatory syringe pumps, and enteral feeding devices. Their range also includes intravenous medication delivery systems and multifunctional infusion therapy devices, along with disposable administration sets. The company emphasizes customization in its offerings, providing project-level adaptations including specialist disposables and software language modifications. Caesarea Medical Electronics caters to clinical research firms and various healthcare environments, including hospitals, home care, and emergency medical settings. Founded in 1993, the company is committed to delivering advanced technology that prioritizes patient safety and ease of use for operators.

CRISI Medical Systems, Inc. is a privately-funded medical device company focused on enhancing the safety and effectiveness of intravenous (IV) injectable medications. The company develops innovative drug delivery systems aimed at improving clinical outcomes and reducing healthcare costs. By prioritizing technology and innovation, CRISI Medical Systems strives to advance the standard of care in injectable drug delivery, ensuring that medications are administered more safely and accurately.

GenCell Biosystems is focused on advancing molecular biology through its innovative Composite Liquid Cell (CLC) platform technology. This technology enables a novel approach to confining, transporting, combining, processing, and analyzing biological reactions, which facilitates the extraction and preparation of samples, library preparation for next-generation sequencing, PCR genotyping, quantitative PCR, digital PCR, and proteomic assays. The versatility of CLCs allows them to be customized to meet diverse protocol requirements, addressing significant challenges in the fields of genomics and proteomics. By commercializing these instruments, GenCell aims to provide valuable tools for researchers in life sciences.

CareFusion is a provider of medical products and enterprise management solutions aimed at enhancing the safety and cost-effectiveness of healthcare. The company offers a range of medical technology products, including automated dispensing systems, patient identification solutions, respiratory ventilators, and surgical instruments that are essential for infection prevention, neurological monitoring, and diagnosis. By focusing on these areas, CareFusion assists healthcare organizations in achieving improvements in infection control, medication management, medical supply management, and respiratory care.

Alverix is a provider of point-of-care diagnostics technology that specializes in the design and manufacture of low-cost, handheld reader devices. These devices offer the precision and accuracy typically associated with laboratory instrumentation. Alverix collaborates with diagnostic and OEM manufacturers to enhance test accuracy, improve portability, and develop new assays suitable for various settings, including physician offices, laboratory outreach locations, retail clinics, and patient homes. With expertise in product design, development, and high-volume manufacturing, Alverix is at the forefront of advancing diagnostic testing from traditional laboratory environments to locations where timely results are essential for patient care.

Cato Software Solutions is a healthcare software developer based in Vienna, Austria. The company specializes in creating an automated system designed to generate and share data, which helps minimize human error and standardize practices within the healthcare sector. Its software offerings include tools for oncologic therapy planning, therapy monitoring, the preparation of cytotoxics, and medication preparation, as well as documentation at the nurse's bedside. Through these solutions, Cato Software Solutions aims to enhance efficiency and accuracy in healthcare delivery.

Safety Syringes, Inc. designs, manufactures, and markets safety devices for the pharmaceutical industry in the United States, Canada, Europe, India, and the Russian Federation. It offers UltraSafe needle guards to attach to prefilled glass syringes used with vaccines, low molecular weight heparins, and other medicines.

Sirigen, Inc. is a biotechnology company based in La Jolla, California, specializing in High Sensitivity Fluorescence (HSF) detection technology for the diagnostic and life science markets. Founded in 2003, Sirigen develops innovative fluorescent polymers and conjugates that enhance stain index performance in flow cytometry. Their products are utilized in a variety of applications, including immunoassays, ELISA, biomarkers, proteomics, molecular diagnostics, and various forms of microscopy and blotting techniques. Sirigen's technology streamlines sample processing and instrumentation requirements, enabling efficient high-volume screening in diagnostics and personal care applications. The company operates as a subsidiary of Becton, Dickinson and Company.

BD Kiestra Total Lab Automation develops solutions and services for medical bacteriology laboratories. It offers total lab and work cell automation solutions, and automation/mechanization modules. The company also provides solutions and products for use in a water or food microbiology laboratories.

Carmel Pharma ab engages in the manufacture and distribution of products that improve the quality of life of people who prepare, administer, and dispose of hazardous drugs. It offers the PhaSeal System, a closed-system drug transfer device that prevents hazardous drug interaction with the environment. The company's PhaSeal product is implemented in various cancer centers, oncology practices, and specialty pharmacies in the United States, as well as facilities in Europe and Asia. Carmel Pharma ab was founded in 1994 and is headquartered in Mölndal, Sweden with an additional office in Columbus, Ohio.

Accuri Cytometers was founded to address a compelling need: life scientists love the rapid cell-by-cell analysis capability of flow cytometers, but too few have a flow cytometer in their lab. The barriers for most researchers include cost of the instrument, complexity of the software, effort required for maintenance, and the large amount of bench space required for the instrument. As a result, the company is looking to develop affordable and robust cytometers.

HandyLab is a medical technology company that develops and manufactures molecular diagnostic assays and automation platforms The company’s proprietary platform reduces the time, cost, and complexity of testing while improving the quality of results. Using patented real-time microfluidic PCR technology, its products are positioned to decentralize nucleic acid testing. HandyLab was founded in 2000 and is based in Ann Arbor, Michigan. It was acquired by Becton, Dickinson and Company in 2009.

Cytopeia Inc., based in Seattle, WA, specializes in manufacturing test and measurement equipment for scientific research. Their primary product is an automated influx cell sorter, designed to help scientists analyze cellular characteristics across diverse applications such as cell therapy research, stem cell research, drug discovery, and marine biology.

Plasso Technology is develops surface-critical research tools utilizing functional coating technology for applications in glycomics and cell culture. The company offers BD Heparin Binding Plate that immobilizes the heparin without modification

TriPath Imaging, Inc. manufactures and markets diagnostic equipment and products for cervical cytology screening. The company’s products include microbial identification tests for differential detection and identification of the causative agents for vaginitis; ethanol based fixative systems to collect, preserve, hemolyze, transport, and transfer cytology specimens to a glass slide; slide profilers for prioritizing slides based on likelihood of abnormality to help cytotechnologists reduce false negatives;

GeneOhm Sciences is a biotechnology company that specializes in the design, development, and delivery of nucleic acid-based diagnostic solutions aimed at addressing unmet diagnostic needs in various diseases, including inherited diseases, infectious diseases, and oncology. Established in 2001 in San Diego, California, and later merging with Infectio Diagnostic, Inc. in 2004, the company leverages a robust portfolio of proprietary technology and industry expertise to create rapid diagnostic systems. These systems are capable of detecting and identifying infectious agents and genetic variations, with a focus on providing FDA-approved molecular tests that deliver results in under two hours. GeneOhm's notable products include the MRSA Assay for detecting methicillin-resistant Staphylococcus aureus and the StrepB Assay for identifying Group B Streptococcus in pregnant women. The company was recently acquired by the BD Pharmaceuticals group, further enhancing its capabilities in the diagnostic field.

ATTO Technology, Inc., based in Amherst, NY, has been a prominent provider of storage and network connectivity solutions for over 25 years, specializing in data-intensive computing environments. The company designs a wide array of products, including Host Bus Adapters, RAID adapters, network adapters, storage controllers, and Thunderbolt™-enabled devices, ensuring high-performance connectivity across various interfaces such as Fibre Channel, SAS, SATA, and iSCSI. ATTO's expertise in engineering advanced technology into practical solutions gives its customers a competitive edge in high-performance computing markets. The company distributes its products globally through Original Equipment Manufacturers, Systems Integrators, Distributors, and Value Added Resellers, providing comprehensive solutions for better data storage, management, and delivery.

StemCo Biomedical, Inc. was founded in 1999 and is located in the Research Triangle Park area of NC. The Company is engaged in the development, manufacture and distribution of a series of medical products designed to improve therapeutic transplantation of adult hematopoetic stem and progenitor cells derived from bone marrow, peripheral blood or umbilical cord blood. Addressing a market of more than $1 billion annually, the Company will have a series of products on the market starting in 2002 that identify, sort and custom-engineer stem cell grafts based upon cellular expression of ALDH resulting in what may be better, more effective stem cell transplants in the future.

GENTEST Corporation specializes in developing innovative systems for the in vitro analysis of xenobiotic metabolism and toxicity, particularly focusing on drug metabolism and toxicology. Founded in 1983, the company initially concentrated on using cultured human cells for genotoxicity assays before expanding its research to include cytochrome P450 cDNA-expression techniques in 1985. This expansion led to the first commercial offering of cDNA-expressed human cytochrome P450 enzymes in 1990. GENTEST is recognized for its expertise in this field, with its scientists contributing to peer-reviewed journals and international symposia. The company’s products are essential for pharmaceutical and biotech industries, providing tools to screen drug candidates for adverse interactions and potential liver toxicity. Over the years, GENTEST has significantly broadened its range of products, enhancing the specificity and activity of its enzymes.

Saf-T-Med, Inc. (STM), a Chicago-based developer of patented needle technology designed to protect health care workers against accidental needlestick injuries.

Clontech Laboratories provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Clontech is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Clontech's mission is to develop high-quality innovative tools and services to accelerate discovery.

As of February 9, 1999, Biometric Imaging, Inc. was acquired by Becton, Dickinson and Company. Biometric Imaging, Inc. develops cell based diagnostic products and high throughput drug discovery technology. Their research is based on a proprietary technology called microvolume fluorimetry, and they primarily serve the transfusion medicine, infectious diseases, and oncology markets. The company was founded in 1991 and is based in Mountain View, California.